星宸科技(301536.SZ):股東昆橋資本及其一致行動人合計持股比例減至5.98%
格隆匯7月30日丨星宸科技(301536.SZ)公佈,公司於近日收到公司持股5%以上股東昆橋資本股權投資管理(深圳)有限公司-昆橋(深圳)半導體科技產業股權投資基金合夥企業(有限合夥)(簡稱“昆橋資本”)及其一致行動人昆宸(深圳)企業管理諮詢合夥企業(有限合夥)(簡稱“昆宸”)出具的《關於減持公司股份觸及1%的整數倍的公告函》,獲悉昆宸在2025年7月1日至2025年7月29日期間通過集中競價交易的方式合計減持62.73萬股,導致持股5%以上股東昆橋資本及其一致行動人昆宸合計持股比例由6.13%減少至5.98%,權益變動觸及1%的整數倍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.